ENZO BIOCHEM INC's ticker is ENZ and the CUSIP is 294100102. A total of 86 filers reported holding ENZO BIOCHEM INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $26,026 | -36.5% | 18,200 | 0.0% | 0.00% | – |
| Q3 2022 | $41,000 | +7.9% | 18,200 | 0.0% | 0.00% | – |
| Q2 2022 | $38,000 | +5.6% | 18,200 | +72.7% | 0.00% | – |
| Q2 2019 | $36,000 | +24.1% | 10,541 | 0.0% | 0.00% | – |
| Q1 2019 | $29,000 | -12.1% | 10,541 | -10.9% | 0.00% | – |
| Q4 2018 | $33,000 | -82.8% | 11,829 | -66.3% | 0.00% | – |
| Q1 2018 | $192,000 | -69.9% | 35,120 | -55.0% | 0.00% | -100.0% |
| Q4 2017 | $637,000 | -29.5% | 78,100 | -9.5% | 0.00% | 0.0% |
| Q3 2017 | $904,000 | -9.6% | 86,300 | -4.7% | 0.00% | 0.0% |
| Q2 2017 | $1,000,000 | +571.1% | 90,550 | +407.9% | 0.00% | – |
| Q1 2017 | $149,000 | +53.6% | 17,830 | -6.8% | 0.00% | – |
| Q3 2016 | $97,000 | – | 19,130 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Roumell Asset Management, LLC | 2,736,719 | $9,414,000 | 13.61% |
| HARBERT FUND ADVISORS, INC. | 5,175,913 | $17,805,000 | 8.40% |
| Evermore Global Advisors, LLC | 2,605,607 | $8,963,000 | 6.32% |
| KEMPNER CAPITAL MANAGEMENT INC. | 95,476 | $328,000 | 0.19% |
| CORRADO ADVISORS, LLC | 46,816 | $161,000 | 0.12% |
| MYDA Advisors LLC | 35,000 | $120,000 | 0.03% |
| Cutter & CO Brokerage, Inc. | 29,827 | $103,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 258,700 | $890,000 | 0.02% |
| Paradigm Financial Partners, LLC | 18,000 | $62,000 | 0.02% |
| Renaissance Technologies | 3,340,864 | $11,493,000 | 0.01% |